SPY329.56-4.95 -1.48%
DIA275.65-3.26 -1.17%
IXIC10,707.42-202.85 -1.86%

HC Wainwright & Co. Reiterates Buy on ZIOPHARM Oncology, Lowers Price Target to $5.5

HC Wainwright & Co. reiterates ZIOPHARM Oncology (NASDAQ:ZIOP) with a Buy and lowers the price target from $6.5 to $5.5.

Benzinga · 05/11/2020 11:22

HC Wainwright & Co. reiterates ZIOPHARM Oncology (NASDAQ:ZIOP) with a Buy and lowers the price target from $6.5 to $5.5.